Diabetes, Obesity & Metabolism
Efficacy and Safety of Chemically Synthesized Semaglutide Injection (HD1916) for the Treatment of Obesity: A Multicenter, Randomized, Phase III Trial
Randomised trial in 462 peopleSemaglutide
Papers by Lihui Zhang
8 results
- Nature Medicine
Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial
Randomised trial in 284 peopleType 2 diabetes - ADA Scientific Sessions 2026 Abstract
MDR-001, an AI-Enabled β-arrestin2-Biased Oral GLP-1RA: Efficacy and Safety in Chinese Adults with Overweight or Obesity
Trial in peopleInterventions
- ADA Scientific Sessions 2026 Abstract
Benefits of HR17031 vs. Insulin Glargine (iGlar) in Patients (pts) with Type 2 Diabetes (T2D) Uncontrolled on Metformin (Met) with/without One Other Oral Antidiabetic Drug (OAD)
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Efficacy and Safety of a Novel Oral Small Molecule GLP-1RA in Chinese Obese Adults without Diabetes
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Efficacy and Safety of a Novel Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist (HRS-7535) in Type 2 Diabetes Mellitus Patients Inadequately Controlled by Metformin
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Efficacy and Safety of a Novel Dual GLP-1/GIP Receptor Agonist in Participants with Type 2 Diabetes Mellitus Up to 32 Weeks
Trial in peopleInterventions